Loading...

Joydeep Mukherjee, PhD

Title(s)Assistant Researcher, Neurological Surgery
SchoolSchool of Medicine
Address1450 3rd Street
San Francisco CA 94158
Phone415-502-7126
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Non-invasive assessment of telomere maintenance mechanisms in brain tumors. Nat Commun. 2021 01 04; 12(1):92. Viswanath P, Batsios G, Mukherjee J, Gillespie AM, Larson PEZ, Luchman HA, Phillips JJ, Costello JF, Pieper RO, Ronen SM. PMID: 33397920.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    2. Bacillus rugosus sp. nov. producer of a diketopiperazine antimicrobial, isolated from marine sponge Spongia officinalis L. Antonie Van Leeuwenhoek. 2020 Nov; 113(11):1675-1687. Bhattacharya D, de Los Santos Villalobos S, Ruiz VV, Selvin J, Mukherjee J. PMID: 32939598.
      View in: PubMed   Mentions:    Fields:    
    3. The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. Neurosurgery. 2020 08 01; 87(2):408-417. Ohba S, Murayama K, Kuwahara K, Pareira ES, Nakae S, Nishiyama Y, Adachi K, Yamada S, Sasaki H, Yamamoto N, Abe M, Mukherjee J, Hasegawa M, Pieper RO, Hirose Y. PMID: 31833548.
      View in: PubMed   Mentions:    Fields:    
    4. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa088. Jones LE, Hilz S, Grimmer MR, Mazor T, Najac C, Mukherjee J, McKinney A, Chow T, Pieper RO, Ronen SM, Chang SM, Phillips JJ, Costello JF. PMID: 32904945.
      View in: PubMed   Mentions:
    5. Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity. Cell Rep. 2020 04 14; 31(2):107518. Ohba S, Johannessen TA, Chatla K, Yang X, Pieper RO, Mukherjee J. PMID: 32294440.
      View in: PubMed   Mentions:    Fields:    
    6. Removal of Pb (II), As (III), and Cr (VI) by nitrogen-starved Papiliotrema laurentii strain RY1. J Basic Microbiol. 2019 Oct; 59(10):1016-1030. Sarkar S, Mukherjee A, Parvin R, Das S, Roy U, Ghosh S, Chaudhuri P, Roychowdhury T, Mukherjee J, Bhattacharya S, Gachhui R. PMID: 31430397.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsPHPublic Health
    7. Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer. Cancer Discov. 2019 06; 9(6):756-777. Chen D, Xia S, Wang M, Lin R, Li Y, Mao H, Aguiar M, Famulare CA, Shih AH, Brennan CW, Gao X, Pan Y, Liu S, Fan J, Jin L, Song L, Zhou A, Mukherjee J, Pieper RO, Mishra A, Peng J, Arellano M, Blum WG, Lonial S, Boggon TJ, Levine RL, Chen J. PMID: 30862724.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    8. HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI. NMR Biomed. 2019 02; 32(2):e4044. Radoul M, Najac C, Viswanath P, Mukherjee J, Kelly M, Gillespie AM, Chaumeil MM, Eriksson P, Delos Santos R, Pieper RO, Ronen SM. PMID: 30561869.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    9. U32 collagenase from Pseudoalteromonas agarivorans NW4327: Activity, structure, substrate interactions and molecular dynamics simulations. Int J Biol Macromol. 2019 Mar 01; 124:635-650. Bhattacharya S, Bhattacharya S, Gachhui R, Hazra S, Mukherjee J. PMID: 30476512.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    10. Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro. Sci Rep. 2018 04 11; 8(1):5805. Wood MD, Mukherjee J, Pieper RO. PMID: 29643433.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    11. Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma. Cancer Res. 2018 06 01; 78(11):2966-2977. Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper RO. PMID: 29545335.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    12. Production enhancement and characterization of the polyhydroxyalkanoate produced by Natrinema ajinwuensis (as synonym) = Natrinema altunense strain RM-G10. Int J Biol Macromol. 2018 Feb; 107(Pt B):1480-1490. Mahansaria R, Dhara A, Saha A, Haldar S, Mukherjee J. PMID: 28987801.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    13. Recent Drug Resistant Epilepsy Spectrum in Eastern India. J Epilepsy Res. 2017 Jun; 7(1):39-44. Mukherjee J, Chakraborty DP, Guha G, Bose B, Saha SP. PMID: 28775954.
      View in: PubMed   Mentions:
    14. Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Res. 2016 11 15; 76(22):6680-6689. Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO. PMID: 27758882.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    15. Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. Mol Cancer Res. 2016 10; 14(10):976-983. Johannessen TA, Mukherjee J, Viswanath P, Ohba S, Ronen SM, Bjerkvig R, Pieper RO. PMID: 27430238.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    16. PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells. Int J Cancer. 2016 Jul 01; 139(1):99-111. Mukherjee J, Ohba S, See WL, Phillips JJ, Molinaro AM, Pieper RO. PMID: 26874904.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    17. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. Cancer Res. 2014 Dec 01; 74(23):7115-24. PMID: 25320009.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    18. Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. Cancer Res. 2014 Sep 01; 74(17):4836-44. PMID: 25035396.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    19. Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme. Mol Cancer. 2013 Jul 15; 12:74. PMID: 23855374.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    20. Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage. PLoS One. 2013; 8(5):e62351. PMID: 23667469.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    21. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma. PLoS One. 2013; 8(2):e57610. PMID: 23451252.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    22. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2013 Jul; 70(1):33-9. PMID: 22851374.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    23. Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency. Cancer Res. 2012 Jul 01; 72(13):3350-9. PMID: 22573716.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    24. Biological response modifiers influence structure function relationship of hematopoietic stem and stromal cells in a mouse model of leukemia. Asian Pac J Cancer Prev. 2012; 13(6):2935-41. PMID: 22938486.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    25. ISOLATION AND CHARACTERIZATION OF CYANOBACTERIA POSSESSING ANTIMICROBIAL ACTIVITY FROM THE SUNDARBANS, THE WORLD'S LARGEST TIDAL MANGROVE FOREST(1). J Phycol. 2011 Aug; 47(4):731-43. Pramanik A, Sundararaman M, Das S, Ghosh U, Mukherjee J. PMID: 27020009.
      View in: PubMed   Mentions: 3     Fields:    
    26. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. Nucl Med Biol. 2011 Oct; 38(7):953-9. PMID: 21982567.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    27. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011 Feb 14; 208(2):313-26. PMID: 21242296.
      View in: PubMed   Mentions: 247     Fields:    Translation:HumansCells
    28. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft. Int J Cancer. 2010 Jan 15; 126(2):563-71. Bhola P, Banerjee S, Mukherjee J, Balasubramanium A, Arun V, Karim Z, Burrell K, Croul S, Gutmann DH, Guha A. PMID: 19634141.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    29. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. Cancer Res. 2009 Nov 15; 69(22):8545-54. Mukherjee J, DeSouza LV, Micallef J, Karim Z, Croul S, Siu KW, Guha A. PMID: 19903856.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    30. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res. 2009 Oct 01; 69(19):7548-56. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A. PMID: 19773446.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    31. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Cancer Res. 2009 Jun 15; 69(12):5099-107. Mukherjee J, Kamnasaran D, Balasubramaniam A, Radovanovic I, Zadeh G, Kiehl TR, Guha A. PMID: 19509233.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    32. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 2008 Dec 15; 68(24):10051-9. Harris MA, Yang H, Low BE, Mukherjee J, Mukherje J, Guha A, Bronson RT, Shultz LD, Israel MA, Yun K. PMID: 19074870.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    33. The other side of the coin: beneficiary effect of 'oxidative burst' upsurge with T11TS facilitates the elimination of glioma cells. Cell Mol Biol (Noisy-le-grand). 2007 May 30; 53(5):53-62. Ghosh A, Mukherjee J, Bhattacharjee M, Sarkar P, Acharya S, Chaudhuri S, Chaudhuri S. PMID: 17543233.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    34. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling. Cancer Invest. 2006 Aug-Sep; 24(5):502-13. Bhattacharjee M, Bose I, Sarkar P, Banerjee C, Dutta S, Ghosh A, Mukherjee J, Acharya S, Goswami S, Mazumdar A, Chaudhuri S, Chaudhuri S. PMID: 16939959.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    35. ENU administration causes genomic instability along with single nucleotide polymorphisms in p53 during gliomagenesis: T11TS administration demonstrated in vivo apoptosis of these genetically altered tumor cells. . 2006 Feb; 5(2):156-64. Mukherjee J, Ghosh A, Ghosh A, Chaudhuri S. PMID: 16357521.
      View in: PubMed   Mentions:
    36. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status. Anticancer Res. 2005 Jul-Aug; 25(4):2905-19. Mukherjee J, Ghosh A, Sarkar P, Mazumdar M, Banerjee C, Chaudhuri S. PMID: 16080544.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    37. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR. Cancer Lett. 2005 May 10; 222(1):23-38. Mukherjee J, Ghosh A, Sarkar S, Mazumdar M, Sarkar P, Duttagupta AK, Chaudhuri S. PMID: 15837538.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    38. Sheep erythrocyte demonstrated better effect than IL-2 and IFN-gamma as biological response modifier against glioma in experimental model. Indian J Exp Biol. 2005 May; 43(5):414-9. Sarkar S, Ghosh A, Dutta S, Roy RU, Begum Z, Mukherjee J, Chaudhuri S, Chaudhuri S. PMID: 15900905.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    39. Advances in the biology of astrocytomas. Curr Opin Neurol. 2004 Dec; 17(6):655-62. Guha A, Mukherjee J. PMID: 15542973.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    40. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis. . 2004 Nov; 3(11):1121-8. Sarkar S, Ghosh A, Mukherjee J, Chaudhuri S, Chaudhuri S. PMID: 15467439.
      View in: PubMed   Mentions:
    41. The first cross sectional survey on intracranial malignancy in Kolkata, India: reflection of the state of the art in southern West Bengal. Asian Pac J Cancer Prev. 2004 Jul-Sep; 5(3):259-67. Ghosh A, Sarkar S, Begum Z, Dutta S, Mukherjee J, Bhattacharjee M, Sarkar P, Banerjee C, Mandal M, Mazumdar A, Bhattacharjee MK, Chaudhuri S, Chaudhuri S. PMID: 15373704.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Immunotherapeutic effects of T11TS/S-LFA3 against nitrosocompound mediated neural genotoxicity. Toxicol Lett. 2004 May 02; 150(3):239-57. Mukherjee J, Sarkar S, Ghosh A, Duttagupta AK, Chaudhuri S, Chaudhuri S. PMID: 15110076.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    43. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj J. 2004; 20(9):515-23. Begum Z, Ghosh A, Sarkar S, Mukherjee J, Mazumdar M, Sarkar P, Chaudhuri S. PMID: 15454689.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    44. A comparative analysis of immunorestoration and recovery with conventional and immunotherapeutic protocols in canine generalized demodicosis: a newer insight of immunotherapeutic efficacy of T11TS. Immunol Invest. 2004; 33(4):453-68. Sarkar P, Mukherjee J, Ghosh A, Bhattacharjee M, Mahato S, Chakraborty A, Mondal M, Banerjee C, Chaudhuri S. PMID: 15624702.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    45. Evaluation of anti-tumor property of specific and non-specific BRMs in experimental gioma by assessing the microglial cell functional and phenotypic modulations. . 2003 Jul-Aug; 2(4):356-63. Begum Z, Sarkar S, Mukherjee J, Ghosh A, Chaudhuri S, Chaudhuri S. PMID: 14508105.
      View in: PubMed   Mentions:
    46. Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3. Asian Pac J Cancer Prev. 2002; 3(4):325-337. Mukherjee J, Dutta S, Sarkar S, Begum Z, Ghosh A, Chaudhuri S, Chaudhuri S. PMID: 12716291.
      View in: PubMed   Mentions: 4     Fields:    
    Joydeep's Networks
    Concepts (316)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑